Back to search results

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Columbia University Irving Medical Center, New York, New York, United States

    Contact: Study coordinator (Mark Stein, MD)

  • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Jason Luke, MD)

  • Peking University Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Lin Shen, MD) · doctorshenlin@sina.cn · 86-13911219511

  • Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Xiaohua Wu, MD) · xu.xh@fudan.edu.cn · 86-13601772486
Study leads

  • Jing Chen, MD

    Study Director

    Ask-Gene Pharma, Inc.

View source on ClinicalTrials.gov(opens in a new tab)